The impact of bottled Prolom water on lithogenesis of urinary tract
Abstract
Urolithiasis represents the most common urological condition nowadays, with rising trend of incidence and prevalence rates, according to geographical, climatic, ethnic, dietary and genetic factors. Prophylactic management of urolithiasis in terms of high fluid intake is of great importance in prevention of all types of urolithiasis. Prolom water has been categorized as a sodium hydro carbonic alkaline hypothermal oligomineral water. The aim of the study was to investigate the effects of bottled Prolom water intake on serum and urinary calcium and magnesium values, as well as on urinary pH and renal microlithiasis. A multicenter prospective trial included a total of 345 patients who had underwent Prolom water intake, in amount of 2,5 to 3 liters/daily, for 14 days, with follow up in three periods. Average values of calcium in serum (mmol/l) at day zero, 7th and 14th were: 2,24; 2,312 and 2,242, separately. Average values of calcium in urine (mmol/l) at day zero, 7th and 14th were: 1,046; 1,582 and 1,564, separately. Average values of magnesium in serum (mmol/l) at day zero, 7th and 14th were: 0,89; 0,82 and 0,81, separately. Average values of magnesium in urine (mmol/l) at day zero, 7th and 14th were: 1,09; 1,51 and 1,61, separately. Mean urinary pH values were: 6,3 at day zero; 5,9 at day 7th; and 6,8 at day 14th. Daily intake of 2,5-3 liters of bottled Prolom water has a favorable and antilithogenic effect on calcium oxalate and calcium phosphate urolithiasis.
References
Alelign T, Petros B. Kidney Stone Disease: An Update on Current Concepts. Adv Urol. 2018 Feb 4;2018:3068365. [CrossRef] [PubMed]
Basavaraj DR, Biyani CS, Browning AJ, J. J. Cartledge JJ. The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU Update Series 2007(5);3:126-136. [CrossRef]
Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomi-zed prospective study. J Urol 1996;155:839. [CrossRef] [PubMed]
Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomi-zed prospective study. J Urol 1996;155(3):839-43. [CrossRef] [PubMed]
Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A 2008;105:9841-6. [CrossRef] [PubMed]
Chen YK, Lin HC, Chen CS, Yeh SD. Seasonal varia-tions in urinary calculi attacks and their association with climate: a population based study. J Urol 2008; 179:564-9. [CrossRef] [PubMed]
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutri-ents and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8. [CrossRef] [PubMed]
Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 2003;44:709. [CrossRef] [PubMed]
Knoll T. Epidemiology, Pathogenesis, and Pathophysio-logy of Urolithiasis. European urology supplements 2010;9:802-806. [CrossRef]
Kompletna fizičko hemijska analiza oligomineralne vode “Prolom“- Banja Prolom. Uzorak: Originalna flaša 1,5 l. Institut za rehabilitaciju. Služba za balneo-klimatologiju. Beograd, Sokobanjska 17. Datum 07.02.2004.
Milović N, Elaković D, Aleksić P. Influences of Prolom water on crystalizatiom factor concentration and inhi-bitors of crystaliyation with patients with urolithiasis. 4th Mediterranean Congress of Urology; 1995; Rhodes, Greece.
Pak CY. Kidney stones. Lancet 1998;351:1797-801 [CrossRef] [PubMed]
Pearle MS, Lotan Y. Urinary Lithiasis: Etiology, Epidemiology, and Pathogenesis. Pathogenesis of upper urinary tract calculi. Table 45-2: Diagnostic Classification of Nephrolithiasis. In: Campbell-Walsh Urology, Tenth Edition, Vol I, Wein AJ, editor in chief; Elsevier Saunders, Philadelphia; 2012. p. 1268-9.
Pearle MS, Lotan Y. Urinary Lithiasis: Etiology, Epidemiology, and Pathogenesis. Physicochemistry: 1260-6. In: Campbell-Walsh Urology, Tenth Edition, Vol I, Wein AJ, editor in chief; Elsevier Saunders, Philadelphia 2012. [CrossRef]
Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: patho-physiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78.
Sarica K, Inal Y, Erturhan S, Yağci F. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res 2006;34:184. [CrossRef] [PubMed]
Sigurjonsdottir VK, Runolfsdottir HL, Indridason OS, Palsson R, Edvardsson VO. Impact of nephrolithiasis on kidney function. BMC Nephrology 2015;16(1):149. [CrossRef] [PubMed]
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States:1976-1994. Kidney Int 2003;63:1817. [CrossRef] [PubMed]
Strauss AL, Coe FL, Deutsch L, Parks JH. Factors that predict relapse of calcium nephrolithiasis during treat-ment: a prospective study. Am J Med 1982;72:17-24. [CrossRef] [PubMed]
Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain and the risk of kidney stones. Journal of the American Medical Association 2005;293(4):455-62. [CrossRef] [PubMed]
Trinchieri A, Curhan G, Karlsen S, Wu KJ. Epide-miology. In: Segura J, Conort P, Khoury S, editors. Stone Disease. Distributed by Editions 21. Paris, France: ICUD; 2003.
Trinchieri A, Ostini F, Nespoli R, Rovera F, Zanetti G. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 1999; 162:27-30. [CrossRef] [PubMed]
Turk C, Neisius A, Petric A, Seitz C, Scolarikos A, Thomas K. Prevalence, aetiology, risk of recurrence. In: EAU Guidelines of urolithiasis (European Associa-tion of Urology 2019, ed; Urolithiasis – limited update March 2019; EAU Guidelines Office, Arnhem, The Netherlands);8-9. https://uroweb.org/guideline/urolithiasis/ [CrossRef] [PubMed]
Umekawa T, Iguchi M, Kurita T. The effect of osteopontin immobilized collagen granules in the seed crystal method. Urol Res. 2001;29(4):282-6. [CrossRef] [PubMed]
Worcester EM, Coe FL. Nephrolithiasis. Primary Care 2008;35(2):369-91. [CrossRef] [PubMed]